United States Flu Vaccine Market Growth, Trends 2021 Size by Regions, Global Industry Share, Sales Revenue and Opportunities till 2026

United States flu vaccine market is expected to reach nearly US$ 3 Billion by 2024. Growth in US flu vaccine market can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against flu vaccine and introduction of quadrivalent flu vaccine.

Flu Vaccine Market Outlook 2024: United States Opportunity and Demand Analysis, Market Forecast 2017-2024” provides a deep and thorough evaluation of the United States flu vaccine market. The report provides an in–depth analysis of the flu vaccination pattern in both Children and Adults in the United States.

It also provides essential insights into flu vaccine production, price, consumption, supply, distribution, demand and specification. It also covers reimbursement pattern and offers a clear view of the regulatory landscape. Additionally, the report includes assessment of clinical trials and promising flu vaccines in the clinical development. Key trends in terms of M&A, collaborations and licensing agreements are analyzed with details.

Click Here to Download Sample Report >>   https://www.kennethresearch.com/sample-request-10077099

The report concludes with the profiles of major players in the US flu vaccine market such as Sanofi Pasteur, GSK and Seqirus. The major market players are evaluated on various parameters such as company overview, product outlook, latest development & trends and sales analysis of flu vaccine market from 2011 to 2022. The report also entails major drivers and inhibitors in the US flu vaccine market.

Major Flu Vaccines Covered Under This Report Are:

• Fluzone High–Dose
• Fluzone Quadrivalent
• Intradermal (ID) Trivalent
• Vaxigrip
• Fluarix Quadrivalent
• Flulaval Quadrivalent
• Flucelvax Quadrivalent
• Afluria Quadrivalent
• Agrippal
• Fluad
• Fluvirin
• FluvaxRequest

Request For Full Report : https://www.kennethresearch.com/sample-request-10077099

Key Companies Covered in This Report:

• Seqirus
• Sanofi Pasteur
• GlaxoSmithKline(GSK)

Key Topics Covered in the Report

  • Market Overview: United States Flu Vaccine Market (2010 – 2024)
  •  United States Number of Persons Vaccinated with Flu Vaccine (2010 – 2024)
  •  United States Flu Vaccine Production, Price, Consumption, Supply, Distribution, Demand and Specification
  •  Reimbursement & Regulatory System in the US Flu Vaccine Market
  •  Mergers, Acquisitions, Key Agreements & Collaborations
  •  Promising Flu Vaccine in Clinical Development
  •  Flu Vaccine Clinical Trial Insights by Phase, Company & Country
  • Key Drivers and Inhibitors of the US Flu Vaccine Market
  •  Key Companies Analysis

Long–term Growth Projection and Development:

  • Sanofi to Acquire Protein Sciences Corporation
  • It is likely that more than 185 Million persons being vaccinated with flu vaccines in 2024.
  •  Nearly 160 Million doses of flu vaccines have shipped to US for the 2017-2018 flu season
  •  It is projected that GSK flu vaccine sales value will reach around US$ 1.5 Billion by 2024
  • BiondVax reports positive phase 2b clinical trial results for its universal flu vaccine


1. Executive Summary

2. Market Overview: United States Flu Vaccine Market (2010 – 2024)

3. United States Number of Persons Vaccinated with Flu Vaccine (2010 – 2024)
3.1 Number of Children Vaccinated
3.2 Number of Adults Vaccinated

4. Key Drivers and Inhibitors of the United States Flu Vaccine Market
4.1 Market Drivers
4.2 Market Inhibitors

5. United States Flu Vaccine Production, Price, Consumption, Supply, Distribution, Demand and Specification
5.1 Flu Vaccine Price Trends
5.1.1 Pediatric Flu Vaccine Price Trends
5.1.2 Adult Flu Vaccine Price Trends
5.2 United States Flu Vaccine Production, Supply, and Allocation (By Companies)
5.3 United States Flu Vaccine Distribution & Demand
5.4 Flu Vaccine Effectiveness
5.5 Managing Flu with Rapid Diagnostic Testing
5.6 Distribution Method of Flu Vaccination

6. United States Flu Vaccine Market – Reimbursement & Regulatory System
6.1 Reimbursement System
6.2 Regulation System

7. Market Dynamics – Mergers, Acquisitions, Key Agreements & Collaborations
7.1 Merger & Acquisitions
7.2 Collaboration Deal
7.3 Licensing, Exclusive & Distribution Agreement Deal
7.3.1 Licensing Agreement
7.3.2 Exclusive Agreement
7.3.3 Distribution Agreement

8. Flu Vaccine – Promising Vaccine in Clinical Development
8.1 Quadrivalent Seasonal Influenza VLP Vaccine
8.2 VN – 100
8.3 Seasonal Influenza VLP Vaccine
8.4 M–001

About Kenneth Research:

Kenneth Research provides market research reports to different individuals, industries, associations and organizations with an aim of helping them to take prominent decisions. Our research library comprises of more than 10,000 research reports provided by more than 15 market research publishers across different industries. Our collection of market research solutions covers both macro level as well as micro level categories with relevant and suitable market research titles. As a global market research reselling firm, Kenneth Research provides significant analysis on various markets with pure business intelligence and consulting services on different industries across the globe. In addition to that, our internal research team always keep a track on the international and domestic market for any economic changes impacting the products’ demand, growth and opportunities for new and existing players.

Contact Us

Kenneth Research
Email: Sales@kennethresearch.com
Phone: +1 313 462 0609

Eli is a freelance writer and possess double graduation degree in physics and chemistry. She is an intense writer covering everything for Science and Tech to Business, Entertainment, Sports and Lifestyle.

Leave a Reply